Bioventus Agrees to Nationwide Contract with Aetna™ Medicare Advantage Plans for DUROLANE® for Knee Osteoarthritis
December 06 2023 - 8:00AM
Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a
global leader in innovations for active healing, has agreed to a
nationwide contract with Aetna™ Medicare Advantage plans. Beginning
January 1, 2024, over 3 million Aetna™ Medicare Advantage plan
members will have access to
DUROLANE to treat knee
osteoarthritis (OA) pain.
DUROLANE, is a
single-injection hyaluronic acid (HA)-based joint-fluid treatment
for patients.
DUROLANE will be one of two
single-injection HA products under contract.
OA involves the breakdown, or degeneration, of cartilage and the
synovial fluid that cushions and lubricates joint tissues.
Injection treatments of HA-based products, such
as DUROLANE, help manage knee OA
pain.
“We are pleased DUROLANE is among the
preferred options available to both Aetna™ Medicare Advantage
members and physicians,” said Anthony Doyle, General Manager, Pain
Treatments and Restorative Therapies for Bioventus. “Both now have
access to a safe HA product that is proven to provide relief from
knee OA pain.”
About Bioventus
Bioventus delivers clinically proven, cost-effective products
that help people heal quickly and safely. Its mission is to make a
difference by helping patients resume and enjoy active lives. The
Innovations for Active Healing from Bioventus include offerings for
Pain Treatments, Restorative Therapies and Surgical Solutions.
Built on a commitment to high quality standards, evidence-based
medicine and strong ethical behavior, Bioventus is a trusted
partner for physicians worldwide. For more information, visit
www.bioventus.com, and follow the Company on LinkedIn and Twitter.
Bioventus and the Bioventus logo are registered trademarks of
Bioventus LLC.
Investor and Media Inquiries:Dave
Crawford919-474-6787dave.crawford@bioventus.com
Bioventus (NASDAQ:BVS)
Historical Stock Chart
From Apr 2024 to May 2024
Bioventus (NASDAQ:BVS)
Historical Stock Chart
From May 2023 to May 2024